It is known that 15–30% overweight/obese adults do not suffer cardiometabolic consequences. There is limited literature examining factors that can be used to assess cardiometabolic health in overweight/obese children. If such factors can be identified, they would aid in differentiating those most in need for aggressive management.
Methods:
Baseline data from 7- to 12-year-old, overweight, and obese children enrolled in a weight management program at an urban hospital were analyzed. Homeostatic model assessment for insulin resistance (HOMA-IR) <2.6 was used to define insulin-sensitive and HOMA-IR ≥2.6 was used to defined insulin-resistant participants. Demographics, physical activity measures, and cardiometabolic risk factors were compared between the two phenotypes. Odds ratios (ORs) examining the association between intermediate endpoints (metabolic syndrome [MetS], nonalcoholic fatty liver disease [NAFLD], systemic inflammation, and microalbuminuria) and the two metabolic phenotypes were evaluated.
Results:
Of the 362 overweight/obese participants, 157 (43.5%) were insulin sensitive and 204 (56.5%) were insulin resistant. Compared to the insulin-sensitive group, the insulin-resistant group was older (8.6±1.6 vs. 9.9±1.7; p<0.001) and had a higher BMI z-score (1.89±0.42 vs. 2.04±0.42; p=0.001). After multivariable adjustment, compared to the insulin-sensitive group, the insulin-resistant group had higher odds of having MetS (OR, 5.47; 95% confidence interval [CI]: 1.72, 17.35; p=0.004) and NAFLD (OR, 8.66; 95% CI, 2.48, 30.31; p=0.001), but not systemic inflammation (OR, 1.06; 95% CI: 0.56, 2.03; p=0.86) or microalbuminuria (OR, 1.71; 95% CI, 0.49, 6.04; p=0.403).
Conclusions:
Using a HOMA-IR value of ≥2.6, clinical providers can identify prepubertal and early pubertal children most at risk. Focusing limited resources on aggressive weight interventions may lead to improvement in cardiometabolic health.
Get full access to this article
View all access options for this article.
References
1.
SongY, MansonJE, MeigsJB, et al.Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol, 2007; 100:1654–1658.
2.
KatzmarzykPT, JanssenI, RossR, et al.The importance of waist circumference in the definition of metabolic syndrome: Prospective analyses of mortality in men. Diabetes Care, 2006; 29:404–409.
3.
MariniMA, SuccurroE, FrontoniS, et al.Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care, 2007; 30:2145–2147.
4.
WildmanRP, MuntnerP, ReynoldsK, et al.The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). [see comment]. Arch Intern Med, 2008; 168:1617–1624.
5.
WeissR, KaufmanFR. Metabolic complications of childhood obesity: Identifying and mitigating the risk. Diabetes Care, 2008; 31(Suppl 2):S310–S316.
6.
GurkaMJ, IceCL, SunSS, et al.A confirmatory factor analysis of the metabolic syndrome in adolescents: An examination of sex and racial/ethnic differences. Cardiovasc Diabetol, 2012; 11:128.
7.
HirschlerV, CalcagnoML, ArandaC, et al.Can the metabolic syndrome identify children with insulin resistance?. Pediatr Diabetes, 2007; 8:272–277.
8.
JuonalaM, ViikariJS, RonnemaaT, et al.Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol, 2006; 26:1883–1888.
9.
DemirciogluF, KocyigitA, ArslanN, et al.Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr, 2008; 47:68–75.
10.
LohmanTG, RocheAF, MartorelliM (eds). Anthropometric Standardization Reference Manual. Human Kinetics Books: Champain, IL, 1988.
11.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 2004; 114:555–576.
12.
TannerJM, WhitehouseRH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child, 1976; 51:170–179.
13.
FreedsonPS, MelansonE, SirardJ. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc, 1998; 30:777–781.
14.
TrostSG, PateRR, SallisJF, et al.Age and gender differences in objectively measured physical activity in youth. Med Sci Sports Exerc, 2002; 34:350–355.
15.
KriskaA, DelahantyL, EdelsteinS, et al.Sedentary behavior and physical activity in youth with recent onset of type 2 diabetes. Pediatrics, 2013; 131:e850–e856.
16.
WeissR, TaksaliSE, DufourS, et al.The “obese insulin-sensitive” adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab, 2005; 90:3731–3737.
17.
YeckelCW, TaksaliSE, DziuraJ, et al.The normal glucose tolerance continuum in obese youth: Evidence for impairment in beta-cell function independent of insulin resistance. J Clin Endocrinol Metab, 2005; 90:747–754.
18.
MatthewsDR, HoskerJP, RudenskiAS, et al.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412–419.
19.
GungorN, SaadR, JanoskyJ, et al.Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr, 2004; 144:47–55.
20.
ConwellLS, TrostSG, BrownWJ, et al.Indexes of insulin resistance and secretion in obese children and adolescents: A validation study. Diabetes Care, 2004; 27:314–319.
21.
AscasoJF, PardoS, RealJT, et al.Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care, 2003; 26:3320–3325.
22.
LeeJM, OkumuraMJ, DavisMM, et al.Prevalence and determinants of insulin resistance among U.S. adolescents: A population-based study. Diabetes Care, 2006; 29:2427–2432.
23.
Toledo-CorralCM, VenturaEE, HodisHN, et al.Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children. Atherosclerosis, 2009; 206:594–598.
24.
DeBoerMD, GurkaMJ, SumnerAE. Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in non-Hispanic black adolescents: An analysis of NHANES 1999–2008. Diabetes Care, 2011; 34:734–740.
25.
CookS, WeitzmanM, AuingerP, et al.Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med, 2003; 157:821–827.
26.
PaiJK, PischonT, MaJ, et al.Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med, 2004; 351:2599–2610.
27.
WangTJ, LarsonMG, LevyD, et al.C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: The Framingham Heart Study. Circulation, 2002; 106:1189–1191.
28.
ReinehrT, KiessW, de SousaG, et al.Intima media thickness in childhood obesity: Relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism, 2006; 55:113–118.
29.
IkonomidisI, StamatelopoulosK, LekakisJ, et al.Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis, 2008; 199:3–11.
30.
SmithSCJr., AmsterdamE, BaladyGJ, et al.Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Tests for silent and inducible ischemia: Writing Group II. Circulation, 2000; 101:E12–E16.
31.
SchwimmerJB, DeutschR, KahenT, et al.Prevalence of fatty liver in children and adolescents. Pediatrics, 2006; 118:1388–1393.
NobiliV, AlisiA, VaniaA, et al.The pediatric NAFLD fibrosis index: A predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med, 2009; 7:21.
34.
GargJP, BakrisGL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med, 2002; 7:35–43.
35.
KlausenK, Borch-JohnsenK, Feldt-RasmussenB, et al.Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation, 2004; 110:32–35.
36.
LjungmanS, WikstrandJ, HartfordM, et al.Urinary albumin excretion—a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens, 1996; 9:770–778.
37.
American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care, 2011; 34(Suppl 1):S11–S61.
38.
American Diabetes Association clinical practice recommendations 2001. Diabetes Care, 2001; 24(Suppl 1):S1–S133.
39.
KarelisAD, FarajM, BastardJP, et al.The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metabol, 2005; 90:4145–4150.
40.
BrochuM, TchernofA, DionneIJ, et al.What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?. J Clin Endocrinol Metabol, 2001; 86:1020–1025.
41.
StefanN, KantartzisK, MachannJ, et al.Identification and characterization of insulin-sensitive obesity in humans. [see comment]. Arch Intern Med, 2008; 168:1609–1616.
42.
MeigsJB, WilsonPW, FoxCS, et al.Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab, 2006; 91:2906–2912.
43.
SteinbergerJ, DanielsSR, EckelRH, et al.Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2009; 119:628–647.
44.
BaoW, SrinivasanSR, BerensonGS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation, 1996; 93:54–59.
45.
SinaikoAR, SteinbergerJ, MoranA, et al.Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation, 2005; 111:1985–1991.
46.
PiliaS, CasiniMR, FoschiniML, et al.The effect of puberty on insulin resistance in obese children. J Endocrinol Invest, 2009; 32:401–405.
47.
PirgonO, BilginH, CekmezF, et al.Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol, 2013; 5:33–39.
48.
RomeoS, KozlitinaJ, XingC, et al.Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet, 2008; 40:1461–1465.
49.
SantoroN, KursaweR, D'AdamoE, et al.A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology, 2010; 52:1281–1290.
50.
DeboerMD, WienerRC, BarnesBH, et al.Ethnic differences in the link between insulin resistance and elevated ALT. Pediatrics, 2013; 132:e718–e726.
51.
LeeCM, HuxleyRR, WildmanRP, et al.Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: A meta-analysis. J Clin Epidemiol, 2008; 61:646–653.
52.
GrundySM, CleemanJI, DanielsSR, et al.Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. [see comment]. [erratum appears in: Circulation, 2005; 112:e297]. Circulation 2005;112:2735–2752.
53.
PerseghinG, ScifoP, DannaM, et al.Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. Am J Physiol Endocrinol Metab, 2002; 283:E556–E564.
54.
SwinburnBA, NyombaBL, SaadMF, et al.Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest, 1991; 88:168–173.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
